Cargando…
Cardiovascular morbidity and the use of inhaled bronchodilators
We used the Manitoba Health database to examine the relationship between use of inhaled respiratory drugs in people with chronic obstructive respiratory diseases and cardiovascular hospitalizations from 1996 through 2000. The drugs examined were beta agonists [BA], ipratropium bromide IB, and inhale...
Autores principales: | Macie, Christine, Wooldrage, Kate, Manfreda, Jure, Anthonisen, Nicholas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528211/ https://www.ncbi.nlm.nih.gov/pubmed/18488440 |
Ejemplares similares
-
Inhaled Bronchodilator Use for Infants with Bronchopulmonary
Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014) -
The role of inhaled and/or nasal corticosteroids on the bronchodilator response
por: Lee, Ju Kyung, et al.
Publicado: (2010) -
Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
por: Corrao, Salvatore, et al.
Publicado: (2017) -
Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017) -
Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
por: Ahmed, Mona Ibrahim, et al.
Publicado: (2023)